Newsroom

Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

11/15/2021, Monday

Bausch + Lomb Reports More Than 41 Million Units of Contact Lens, Eye and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs

11/15/2021, Monday

Bausch + Lomb Reports More Than 41 Million Units of Contact Lens, Eye and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs

11/01/2021, Monday

Bausch + Lomb Will Present Scientific Data and Analyses during the American Academy of Ophthalmology and American Academy of Optometry Annual Meetings

10/27/2021, Wednesday

Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration with TerraCycle in the United States

10/25/2021, Monday

Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (Triamcinolone Acetonide Injectable Suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis

09/30/2021, Thursday

Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial of NOV03 (Perfluorohexyloctane) in Dry Eye Disease Associated With Meibomian Gland Dysfunction

07/19/2021, Monday

Bausch + Lomb Will Present 14 Scientific Posters Featuring New Analyses Involving its Surgical Technologies at the 2021 Annual Meeting of the American Society of Cataract and Refractive Surgery

07/12/2021, Monday

Bausch + Lomb Launches Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes

07/07/2021, Wednesday

Bausch + Lomb Completes Enrollment of Second Phase 3 Study for NOV03 (perfluorohexyloctane)

06/23/2021, Wednesday

Bausch + Lomb Expands Parameters for Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses

06/08/2021, Tuesday

Bausch + Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE™ Clinical Decision Support Software

06/02/2021, Wednesday

Bausch + Lomb and Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension)

06/01/2021, Tuesday

Bausch + Lomb and Prevent Blindness Launch Educational Campaign During Cataract Awareness Month

05/11/2021, Tuesday

New National Eye Institute Data Shows AREDS2 Nutrient Formula Continues to Reduce the Risk of Moderate to Advanced Age-Related Macular Degeneration Progression

04/29/2021, Thursday

Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting

04/29/2021, Thursday

Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting

04/13/2021, Tuesday

Bausch + Lomb Announces Statistically Significant Topline Results from the First Phase 3 Trial of Nov03 (Perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysfunction

04/07/2021, Wednesday

FDA Approves Bausch + Lomb ClearVisc™ Dispersive Ophthalmic Viscosurgical Device (OVD)

02/23/2021, Tuesday

Bausch + Lomb Launches Alaway® Preservative Free Antihistamine Eye Drops

02/01/2021, Monday

Prevent Blindness and Bausch + Lomb to Launch Year-Long Video Series to Raise Awareness of Age-Related Macular Degeneration (AMD)

12